Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

295
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
295
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

278
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
278
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

281
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
281
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

234
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
234

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in admission to trauma centres by sex among adults with traumatic brain injury: a population-based cohort study.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Palliative and End-of-Life Care Utilization in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Population-Based Study.

JACC. Advances·2026
Same author

Use of Double Sequential External Defibrillation in the United States Before and After the DOSE VF Randomized Clinical Trial.

Prehospital emergency care·2026
Same author

The Impact of Trauma Center Care on One-Year Outcomes Among Injured Older Adults: A Population-Based Cohort Study.

Annals of surgery·2026
Same author

The need for long-term support: Five-year outcomes after severe injury in older adults.

Injury·2026
Same author

Reporting practices and impact of withdrawal of life-sustaining treatment on outcomes in acute brain injury clinical trials: a literature review and simulation study.

Critical care (London, England)·2026

Related Experiment Video

Updated: Nov 28, 2025

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
07:56

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

1.1K

DOuble SEquential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF): study protocol for a

Ian R Drennan1,2,3, Paul Dorian4, Shelley McLeod5,6

  • 1Sunnybrook Centre for Prehospital Medicine, Sunnybrook Health Sciences Centre, 77 Brown's Line, Suite 100, Toronto, Ontario, M8W 3S2, Canada. Ian.Drennan@Sunnybrook.ca.

Trials
|November 27, 2020
PubMed
Summary

This study compares double sequential external defibrillation (DSED) and vector change (VC) defibrillation to standard treatment for refractory ventricular fibrillation (VF) during out-of-hospital cardiac arrest. It aims to determine if these novel strategies improve survival to hospital discharge.

Keywords:
Cardiopulmonary resuscitationCluster randomized controlled trialDouble sequential defibrillationEmergency medical servicesOut-of-hospital cardiac arrestVentricular fibrillation

More Related Videos

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.2K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.1K

Related Experiment Videos

Last Updated: Nov 28, 2025

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
07:56

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

1.1K
A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.2K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.1K

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Clinical Trials

Background:

  • Refractory ventricular fibrillation (VF) during out-of-hospital cardiac arrest (OHCA) is associated with poor patient outcomes despite advanced resuscitation efforts.
  • Novel defibrillation strategies, including double sequential external defibrillation (DSED) and vector change (VC) defibrillation, have been proposed for refractory VF/pulseless ventricular tachycardia (pVT).
  • Current evidence supporting these alternative defibrillation techniques remains inconclusive, necessitating further investigation.

Purpose of the Study:

  • To compare the efficacy of DSED and VC defibrillation against standard defibrillation in adult patients experiencing refractory VF/pVT during OHCA.
  • To evaluate whether DSED or VC defibrillation leads to increased survival rates to hospital discharge compared to standard defibrillation.
  • To assess secondary outcomes including return of spontaneous circulation (ROSC) and the number of defibrillation attempts required.

Main Methods:

  • A three-arm, cluster randomized trial with repeated crossover design will be conducted over three years in six regions of Ontario, Canada.
  • Adult patients (≥18 years) with refractory VF/pVT (defined as persistent VF/pVT after three standard defibrillation attempts) will be randomized to receive standard defibrillation, DSED, or VC defibrillation.
  • The primary outcome is survival to hospital discharge, with secondary outcomes including ROSC and VF termination rates.

Main Results:

  • This section is not applicable as the study is prospective and results are not yet available.

Conclusions:

  • A well-designed randomized controlled trial is essential to evaluate the impact of DSED and VC defibrillation on clinical outcomes in refractory VF.
  • Standardized approaches to alternative defibrillation strategies are needed to guide clinical practice and improve survival rates in OHCA patients with refractory VF/pVT.